Resistance to policy change originated
primarily from clinicians both inside and outside of government,
and centred on concerns about the ability of CHWs to offer
quality care, and the potential consequences of inappropriate use of
antibiotics by this cadre. Further, Kenyan policy makers identified
differences in their context that led them to question the applicability
of evidence on iCCM effectiveness from elsewhere. Addressing
these concerns would require greater clarity about mechanisms to